A New Era of Prospective Real-World Safety Evaluation: Primary Report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System Condition-of-Approval Post-Market Study)

Abstract
No abstract available
Funding Information
  • Abbott Vascular

This publication has 19 references indexed in Scilit: